EUVIMEDEUVIMED entdecken
Crossref

The effects of tranexamic acid in patients treated with extracorporeal membrane oxygenation after cardiac surgery

Wei Chen, Zhongtao Du, Liangshan Wang iD, Mengjun Wang, Hong Wang, Xiaotong Hou iD

Perfusion · 2025

DOI: 10.1177/02676591241242641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Perfusion, 2025. Verfasst von Wei Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Tranexamic Acid, Extracorporeal Membrane Oxygenation, Cardiac Surgical Procedures, Antifibrinolytic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Beijing Hospitals Authority Clinical Medicine, Beijing Hospitals Authority “Ascent Plan”, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The lysine analog tranexamic acid (TXA) is used as a blood protective drug in cardiac surgery, but efficacy and safety outcomes in patients treated with extracorporeal membrane oxygenation (ECMO) after surgery remain poorly understood.

Methods

From January 1, 2017 to December 31, 2022, we retrospectively analyzed patients assisted by ECMO after cardiac surgery and divided them into TXA and control groups depending on whether TXA was used or not. The primary study outcome was red blood cell (RBC) transfusion during ECMO.

Results

In total, 321 patients treated with ECMO after cardiac surgery were assessed; 185 patients were eligible for inclusion into to the TXA-intervention group and 136 into to the control group. RBC transfusion during ECMO was 8.0 IU (4.0 IU–14.0 IU) in the TXA group versus 10.0 IU (6.0 IU–16.0 IU) in the control group ( p = .034). Median total chest drainage volume after surgery was 1460.0 mL (650.0–2910.0 mL) and 1680.0 mL (900.0–3340.0 mL) in TXA and control groups, respectively ( p = .021). Postoperative serum D-dimer levels were significantly lower in the TXA group when compared with the control group; 1.125 µg/mL (0.515–2.176 µg/mL) versus 3.000 µg/mL (1.269–5.862 µg/mL), p < .001. Serious adverse events, including vascular occlusive events, did not differ meaningfully between groups.

Conclusions

In patients treated with ECMO after cardiac surgery, TXA infusion modestly but significantly reduced RBC transfusions and chest tube output when compared with the control group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidExtracorporeal Membrane OxygenationCardiac Surgical ProceduresAntifibrinolytic AgentsHumansMaleFemaleMiddle AgedRetrospective StudiesAged

Stichwörter der Autor:innen

cardiac surgeryextracorporeal membrane oxygenationtranexamic acid

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Liangshan Wang, Xiaotong Hou

Förderung

  • Beijing Hospitals Authority Clinical Medicine
  • Beijing Hospitals Authority “Ascent Plan”
  • National Natural Science Foundation of China
  • Beijing Nova Program
  • Beijing Municipal Natural Science Foundation
  • China Association for Science and Technology
  • Beijing Hospitals Authority Youth Programme

Zitieren

APA

Chen, W., Du, Z., Wang, L., Wang, M., Wang, H., & Hou, X. (2025). The effects of tranexamic acid in patients treated with extracorporeal membrane oxygenation after cardiac surgery. Perfusion. https://doi.org/10.1177/02676591241242641

Vancouver

Chen W, Du Z, Wang L, Wang M, Wang H, Hou X. The effects of tranexamic acid in patients treated with extracorporeal membrane oxygenation after cardiac surgery. Perfusion. 2025. doi:10.1177/02676591241242641

BibTeX
@article{Chen2025,
  author = {Chen, Wei and Du, Zhongtao and Wang, Liangshan and Wang, Mengjun and Wang, Hong and Hou, Xiaotong},
  title = {The effects of tranexamic acid in patients treated with extracorporeal membrane oxygenation after cardiac surgery},
  journal = {Perfusion},
  year = {2025},
  doi = {10.1177/02676591241242641}
}
Kostenlos starten →